Faculty PublicationsA collection of AUN faculty publicationshttp://hdl.handle.net/123456789/3552026-07-17T11:00:08Z2026-07-17T11:00:08ZREPORT ON ORAL HEALTH PROMOTION IN SCHOOLS AND PRIMARY HEALTH SERVICES IN HOST COMMUNITIES OF INTERNALLY DISPLACED PERSONS IN NIGERIA :Tyndall, Jennifer.Inyang, Victory.Adikpo, Janet.http://hdl.handle.net/123456789/7222025-03-29T08:11:14Z2025-01-01T00:00:00ZREPORT ON ORAL HEALTH PROMOTION IN SCHOOLS AND PRIMARY HEALTH SERVICES IN HOST COMMUNITIES OF INTERNALLY DISPLACED PERSONS IN NIGERIA :
Tyndall, Jennifer.; Inyang, Victory.; Adikpo, Janet.
The oral health program on Oral Health Promotion in Schools and Primary Health Services in Host Communities of Internally Displaced Persons’ (IDP’s) in Nigeria was launched on January 25, 2022. This project took place in three different Local Government Areas (LGAs), Fufore, Girei, Yola South and covered six different communities, Malkohi (Yola South LGA), Sangere Sabon Gari, Damare (Girei LGA), Pariya, Daware, Farang, and Wuro Bokki (Fufore LGA).
The implementation of the Oral Health Project was divided into five phases. These included identification and selection of Community Health Workers (CHWs), the training of selected CHWs on Oral Health, Hygiene and awareness by Dr. David Laban at the American University of Nigeria (AUN) with valuable inputs on Oral Health and Hygiene from affiliated health agencies including Dr. Ibrahim Sahabo from the Adamawa State Primary Healthcare Development Agency, Dr. Emmanuel Pembi and Dr. Ahemen Terseer from the World Health Organization (WHO), Dr. Dogara Paul from AUN Health Services, Dr. Mohammed Chubado from the Adamawa State Agency for the Control of HIV/AIDS (SACA), Dr. Nasiru Mohammed from Achieving Health Nigeria Initiative.
According to the World Health Organization, an estimated 3.5 billion people worldwide are
affected by oral diseases, with 3 out of 4 people living in low-resource countries (WHO, 2023). The 2022 Global Oral Health report published by the WHO shows that most cases of oral diseases are dental caries, periodontal diseases, tooth loss and oral cancers, with untreated dental caries in permanent teeth as the most common oral condition (WHO, 2022). Other oral diseases and conditions that are a public health concern are orofacial clefts, Noma, and oro-dental trauma (WHO, 2023).
Oral disease, while preventable and treatable to a very large extent when detected early, pose a major health burden for many countries, and can interfere with the ability of people to lead normal lives. The burden of oral diseases has high social, economic, and health systems consequences. It is also an indication of significant inequalities in the society. For example, noma, an oral disease that disfigures the mouth and face, can be fatal if left untreated. The disease, which is primarily found in Sub-Saharan Africa, is a marker of extreme poverty (WHO, 2016). Fortunately, with the help of proven and cost-effective interventions, these people need not suffer needlessly, or in worst case scenarios, die.
2025-01-01T00:00:00ZResearching and Teaching Entrepreneurial Marketing in Silicon Valley /Eggers, Fabian.http://hdl.handle.net/123456789/7212025-02-20T15:24:43Z2025-03-28T00:00:00ZResearching and Teaching Entrepreneurial Marketing in Silicon Valley /
Eggers, Fabian.
Entrepreneurship:
• Can be found in all kinds of organizations (young/established, small/large,
public/private)
• Is a process of value generation through the creation of a unique combination of
resources aimed at the utilization of opportunities (Stevenson et al., 1989)
• Rests on the concept of (proactive) entrepreneurial orientation (EO)
Marketing:
• Is an “organizational function and a set of processes for creating, communicating
and delivering value to customers and for managing customer relationships in
ways that benefit the organization and its stakeholders” (Keefe, 2004, p.17)
• Core of the marketing concept: the ability of the enterprise to solve customer
problems
• Rests on the concept of (reactive) customer orientation (CO)
2025-03-28T00:00:00ZArtificial Intelligence: Leveraging AI to Enhance Workplace Effectiveness /ABUBAKAR, AMINA.http://hdl.handle.net/123456789/7202025-02-20T15:10:49Z2025-04-10T00:00:00ZArtificial Intelligence: Leveraging AI to Enhance Workplace Effectiveness /
ABUBAKAR, AMINA.
Artificial Intelligence is about making computers and machines do things that normally require human intelligence. It's like teaching a computer to learn, solve problems, and understand things, but using code and data instead of a brain.
A training session for the non academic staff of the American University of Nigeria
2025-04-10T00:00:00ZWhole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virusDiaz-Ca´nova, Diana.Moens, Ugo.Brinkmann, AnnikaNitsche, Andreas.Okeke, Malachy Ifeanyi.http://hdl.handle.net/123456789/7092024-10-13T13:28:59Z2024-04-03T00:00:00ZWhole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus
Diaz-Ca´nova, Diana.; Moens, Ugo.; Brinkmann, Annika; Nitsche, Andreas.; Okeke, Malachy Ifeanyi.
Modified vaccinia virus Ankara (MVA) has been widely tested in clinical trials as recombinant vector vaccine against infectious diseases and cancers in humans and animals. However, one biosafety concern about the use of MVA vectored vaccine is the potential for MVA to recombine with naturally occurring orthopoxviruses in cells and hosts in which it multiplies poorly and, therefore, producing viruses with mosaic genomes with altered genetic and phenotypic properties. We previously conducted co-infection and superinfection experiments with MVA vectored influenza vaccine (MVA-HANP) and a feline Cowpox virus (CPXV-No-F1) in Vero cells (that were semi-permissive to MVA infection) and showed that recombination occurred in both co-infected and superinfected cells. In this study, we selected the putative recombinant viruses and performed genomic characterization of these viruses. Some putative recombinant viruses displayed plaque morphology distinct of that of the parental viruses. Our analysis demonstrated that they had mosaic genomes of different lengths. The recombinant viruses, with a genome more similar to MVA-HANP (>50%), rescued deleted and/or fragmented genes in MVA and gained new host ranges genes. Our analysis also revealed that some MVA-HANP contained a partially deleted transgene expression cassette and one recombinant virus contained part of the transgene expression cassette similar to that incomplete MVA-HANP. The recombination in co-infected and superinfected Vero cells resulted in recombinant viruses with unpredictable biological and genetic properties as well as recovery of delete/fragmented genes in MVA and transfer of the transgene into replication competent CPXV. These results are relevant to hazard characterization and risk assessment of MVA vectored biologicals.
The Orthopoxvirus genus belongs to the Poxviridae family. The orthopoxviruses (OPXV) are viruses with large linear double stranded DNA genome (170 to 250kbp) (1). OPXV can infect vertebrates and insects (2). Among the OPXV that cause human diseases, Variola virus (VARV), vaccinia-like virus, Cowpox virus (CPXV) and Monkeypox virus (MPXV) are the most common (3–6). VARV is the causative agent of smallpox, a deadly viral disease, which was eradicated in 1980 as a result of a massive vaccination campaign (7). During the smallpox campaign, Vaccinia virus (VACV) was used as the smallpox vaccine and several VACV strains have been developed and used in different countries, such as New York City Board of Health (NYCBH) was used in the America, Tian tan in China, Ankara in Turkey, and Lister and modified vaccinia virus Ankara (MVA) in Europe (8–10).
2024-04-03T00:00:00Z